skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 735,736  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Material Type:
Article
Add to My Research

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

Gut, 2012-03, Vol.61 (3), p.416-426 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;2015 INIST-CNRS ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2011-300304 ;PMID: 21813474 ;CODEN: GUTTAK

Full text available

2
PNPLA3 I148M polymorphism and progressive liver disease
Material Type:
Article
Add to My Research

PNPLA3 I148M polymorphism and progressive liver disease

World journal of gastroenterology : WJG, 2013-11, Vol.19 (41), p.6969-6978

2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013 ;ISSN: 1007-9327 ;EISSN: 2219-2840 ;DOI: 10.3748/wjg.v19.i41.6969 ;PMID: 24222941

Full text available

3
Hypoxia-inducible factors as molecular targets for liver diseases
Material Type:
Article
Add to My Research

Hypoxia-inducible factors as molecular targets for liver diseases

Journal of Molecular Medicine, 2016-06, Vol.94 (6), p.613-627 [Peer Reviewed Journal]

The Author(s) 2016 ;Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 0946-2716 ;EISSN: 1432-1440 ;DOI: 10.1007/s00109-016-1408-1 ;PMID: 27094811

Full text available

4
Molecular pathways of nonalcoholic fatty liver disease development and progression
Material Type:
Article
Add to My Research

Molecular pathways of nonalcoholic fatty liver disease development and progression

Cellular and molecular life sciences : CMLS, 2019-01, Vol.76 (1), p.99-128 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2018 ;Cellular and Molecular Life Sciences is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 1420-682X ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-018-2947-0 ;PMID: 30343320

Full text available

5
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
Material Type:
Article
Add to My Research

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

The American journal of gastroenterology, 2017-01, Vol.112 (1), p.18-35 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jan 2017 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1038/ajg.2016.517 ;PMID: 27995906

Full text available

6
Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics
Material Type:
Article
Add to My Research

Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics

Nutrients, 2018-10, Vol.10 (10), p.1457 [Peer Reviewed Journal]

2018 by the authors. 2018 ;ISSN: 2072-6643 ;EISSN: 2072-6643 ;DOI: 10.3390/nu10101457 ;PMID: 30297615

Full text available

7
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article
Add to My Research

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv238-iv255 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy308 ;PMID: 30285213

Full text available

8
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Material Type:
Article
Add to My Research

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver

The Journal of clinical investigation, 2012-08, Vol.122 (8), p.2871-2883 [Peer Reviewed Journal]

COPYRIGHT 2012 American Society for Clinical Investigation ;COPYRIGHT 2012 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Aug 2012 ;Copyright © 2012, American Society for Clinical Investigation 2012 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci63539 ;PMID: 22820288

Full text available

9
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
Material Type:
Article
Add to My Research

A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease

PLoS genetics, 2020-04, Vol.16 (4), p.e1008629 [Peer Reviewed Journal]

2020 Emdin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Emdin et al 2020 Emdin et al ;ISSN: 1553-7404 ;ISSN: 1553-7390 ;EISSN: 1553-7404 ;DOI: 10.1371/journal.pgen.1008629 ;PMID: 32282858

Full text available

10
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Material Type:
Article
Add to My Research

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2019-04, Vol.156, p.1264-1281.e4 [Peer Reviewed Journal]

Attribution - NonCommercial ;ISSN: 0016-5085 ;EISSN: 1528-0012 ;DOI: 10.1053/j.gastro.2018.12.036

Digital Resources/Online E-Resources

11
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Material Type:
Article
Add to My Research

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

The Journal of clinical investigation, 2012-08, Vol.122 (8), p.2884-2897 [Peer Reviewed Journal]

COPYRIGHT 2012 American Society for Clinical Investigation ;COPYRIGHT 2012 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Aug 2012 ;Copyright © 2012, American Society for Clinical Investigation 2012 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci63455 ;PMID: 22820290

Full text available

12
Liver cirrhosis
Material Type:
Article
Add to My Research

Liver cirrhosis

The Lancet (British edition), 2021-10, Vol.398 (10308), p.1359-1376 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01374-X ;PMID: 34543610

Full text available

13
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
Material Type:
Article
Add to My Research

Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study

Hepatology (Baltimore, Md.), 2020-09, Vol.72 (3), p.892-905 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0270-9139 ;EISSN: 1527-3350 ;DOI: 10.1002/hep.31108 ;PMID: 31943293

Digital Resources/Online E-Resources

14
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
Material Type:
Article
Add to My Research

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

BMC medicine, 2019-05, Vol.17 (1), p.95-95, Article 95 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-019-1321-x ;PMID: 31104631

Full text available

15
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
Material Type:
Article
Add to My Research

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

World journal of gastroenterology : WJG, 2018-08, Vol.24 (30), p.3361-3373

The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. 2018 ;ISSN: 1007-9327 ;EISSN: 2219-2840 ;DOI: 10.3748/wjg.v24.i30.3361 ;PMID: 30122876

Full text available

16
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Material Type:
Article
Add to My Research

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

Diabetes care, 2020-02, Vol.43 (2), p.290-297 [Peer Reviewed Journal]

2019 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1071 ;PMID: 31604692

Full text available

17
A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD
Material Type:
Article
Add to My Research

A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD

Scientific reports, 2020-02, Vol.10 (1), p.2771-2771, Article 2771 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-59535-w ;PMID: 32066758

Full text available

18
The Natural Course of Non-Alcoholic Fatty Liver Disease
Material Type:
Article
Add to My Research

The Natural Course of Non-Alcoholic Fatty Liver Disease

International journal of molecular sciences, 2016-05, Vol.17 (5), p.774-774 [Peer Reviewed Journal]

2016 by the authors; licensee MDPI, Basel, Switzerland. 2016 ;ISSN: 1422-0067 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms17050774 ;PMID: 27213358

Full text available

19
From NASH to HCC: current concepts and future challenges
Material Type:
Article
Add to My Research

From NASH to HCC: current concepts and future challenges

Nature reviews. Gastroenterology & hepatology, 2019-07, Vol.16 (7), p.411-428 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Springer Nature Limited 2019. ;ISSN: 1759-5045 ;EISSN: 1759-5053 ;DOI: 10.1038/s41575-019-0145-7 ;PMID: 31028350

Full text available

20
Vitamin D supplementation for chronic liver diseases in adults
Material Type:
Article
Add to My Research

Vitamin D supplementation for chronic liver diseases in adults

Cochrane database of systematic reviews, 2017-11, Vol.2017 (11), p.CD011564-CD011564 [Peer Reviewed Journal]

Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011564.pub2 ;PMID: 29099543

Full text available

Results 1 - 20 of 735,736  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (641,814)

Refine My Results

Creation Date 

From To
  1. Before 1957  (10,064)
  2. 1957 To 1973  (44,104)
  3. 1974 To 1990  (122,088)
  4. 1991 To 2008  (222,532)
  5. After 2008  (335,876)
  6. More options open sub menu

Subject 

  1. Science & Technology  (543,959)
  2. Life Sciences & Biomedicine  (512,116)
  3. Humans  (327,732)
  4. Animals  (273,128)
  5. Male  (263,760)
  6. Biological And Medical Sciences  (198,803)
  7. Female  (195,988)
  8. Liver  (181,073)
  9. Medical Sciences  (162,547)
  10. Rats  (135,454)
  11. Middle Aged  (116,107)
  12. Adult  (102,892)
  13. Liver - Metabolism  (100,979)
  14. Gastroenterology. Liver. Pancreas. Abdomen  (93,460)
  15. Biochemistry & Molecular Biology  (80,913)
  16. Aged  (79,288)
  17. Mice  (79,139)
  18. Gastroenterology & Hepatology  (76,379)
  19. Tumors  (72,291)
  20. Oncology  (68,153)
  21. More options open sub menu

Language 

  1. English  (709,105)
  2. Japanese  (101,041)
  3. German  (6,417)
  4. French  (5,581)
  5. Portuguese  (3,832)
  6. Spanish  (3,709)
  7. Korean  (3,160)
  8. Chinese  (2,557)
  9. Swedish  (2,217)
  10. Russian  (1,374)
  11. Norwegian  (1,024)
  12. Turkish  (534)
  13. Danish  (447)
  14. Persian  (370)
  15. Polish  (367)
  16. Italian  (231)
  17. Ukrainian  (160)
  18. Croatian  (106)
  19. Dutch  (98)
  20. Arabic  (86)
  21. More options open sub menu

Searching Remote Databases, Please Wait